CART Cell Therapy
Showing 9951 - 9975 of >10,000
Childhood Cancer Trial in Munich (Single high-intensity interval exercise intervention)
Completed
- Childhood Cancer
- Single high-intensity interval exercise intervention
-
Munich, GermanyKinderklinik München Schwabing, TUM School of Medicine, Departme
Oct 25, 2021
Non Small Cell Lung Cancer Trial in Changsha (IBI-322 Plus Lenvatinib and Platinum)
Not yet recruiting
- Non Small Cell Lung Cancer
- IBI-322 Plus Lenvatinib and Platinum
-
Changsha, Hunan, ChinaHunan Cancer hospital
Jul 14, 2022
Spasticity/Paresis, Cerebral Palsy Trial (device, drug, other, behavioral)
Not yet recruiting
- Spasticity/Paresis
- Cerebral Palsy
- ESWT
- +4 more
- (no location specified)
Nov 15, 2023
Hereditary Hemochromatosis, Hyperferritinemia Trial in Basel, Berne (Venipuncture)
Enrolling by invitation
- Hereditary Hemochromatosis
- Hyperferritinemia
- Venipuncture
-
Basel, Switzerland
- +1 more
Feb 14, 2023
Parkinson Disease Trial in Porto Alegre (Physiotherapy on the ground, Aquatic physiotherapy, Power training)
Active, not recruiting
- Parkinson Disease
- Physiotherapy on the ground
- +2 more
-
Porto Alegre, RS, BrazilUniversidade de Ciências da Saúde de Porto Alegre
May 18, 2023
Esophageal Squamous Cell Dysplasia Trial in Beijing (CryoBalloon Focal Ablation System)
Completed
- Esophageal Squamous Cell Dysplasia
- CryoBalloon Focal Ablation System
-
Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
Apr 18, 2022
Ventilation Heterogeneity Prior to Lung Resection
Enrolling by invitation
- Lung Cancer
- Hyperpolarized 129Xe MRI
- +2 more
-
Hamilton, Ontario, CanadaFirestone Institute for Respiratory Health, Research - St. Josep
Jan 18, 2023
Pancreatic Cancer, Cancer of the Pancreas Trial in Philadelphia (huCART-meso cells)
Recruiting
- Pancreatic Cancer
- Cancer of the Pancreas
- huCART-meso cells
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Dec 9, 2022
HLHS Trial in United States (Longeveron Mesenchymal Stem Cells)
Completed
- HLHS
- Longeveron Mesenchymal Stem Cells
-
Atlanta, Georgia
- +4 more
Mar 4, 2022
Myeloid Leukemia, Chronic Trial in Berlin, Bremen (DC vaccine)
Recruiting
- Myeloid Leukemia, Chronic
- DC vaccine
-
Berlin, Germany
- +1 more
Aug 3, 2021
Leber Hereditary Optic Neuropathy (LHON) Trial (NFS-02 Injection)
Not yet recruiting
- Leber Hereditary Optic Neuropathy (LHON)
- NFS-02 Injection
- (no location specified)
Apr 6, 2023
Medical and Surgical Therapy and Pathogenetic Considerations
Recruiting
- Endometriosis of Umbilicus
- +3 more
- Patients satisfaction after medical and surgical treatment for umbilical endometriosis
-
Milan, ItalyFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
May 5, 2022
Insulin Pump,Continuous Glucose Monitoring Technology Trial in Guandong (Insulin Glargine, Metformin, Dapagliflozin)
Recruiting
- Insulin Pump,Continuous Glucose Monitoring Technology
- Insulin Glargine
- +3 more
-
Guandong, China刘烈华
Nov 7, 2023
Squamous Cell Carcinoma of the Head and Neck Trial in La Jolla, San Francisco, Torrance (Pembrolizumab)
Active, not recruiting
- Squamous Cell Carcinoma of the Head and Neck
-
La Jolla, California
- +2 more
Aug 17, 2022
90K/Mac-2 BP asIndicator of Early Response to Infliximab Therapy
Not yet recruiting
- IBD
- 90K
- (no location specified)
Jul 18, 2023
Low Back Pain Trial (AXOMOVE Therapy Medical Device)
Not yet recruiting
- Low Back Pain
- AXOMOVE Therapy Medical Device
- (no location specified)
Jun 15, 2023
Prostate Cancer Trial in Philadelphia (Proton Beam Radiation Therapy, Quality-of-Life assessment, Questionnaire Administration)
Terminated
- Prostate Cancer
- Proton Beam Radiation Therapy
- +2 more
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Jan 30, 2023
Esophageal Squamous Cell Carcinoma, HER-2 Protein Overexpression, HER-2 Gene Amplification Trial in Copenhagen, Odense
Recruiting
- Esophageal Squamous Cell Carcinoma
- +2 more
-
Copenhagen, Region H, Denmark
- +1 more
Aug 10, 2022
Stroke, Infarction, Middle Cerebral Artery Trial in Guangzhou (Autologous BMSCs transplantation, Autologous EPCs
Completed
- Stroke
- Infarction, Middle Cerebral Artery
- Autologous BMSCs transplantation
- +2 more
-
Guangzhou, Guangdong, ChinaZhujiang Hospital, Southern Medical University
Apr 1, 2021
Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor Grade 1 Trial ([203Pb]VMT-a-NET, SPECT/CT)
Enrolling by invitation
- Neuroendocrine Tumor Grade 2
- Neuroendocrine Tumor Grade 1
- [203Pb]VMT-α-NET
- SPECT/CT
-
Iowa City, IowaThe University of Iowa
Dec 9, 2022
HER2/Neu Negative, No Evidence of Disease, One or More Positive Axillary Nodes Trial in Seattle, Madison (Laboratory Biomarker
Active, not recruiting
- HER2/Neu Negative
- +10 more
- Laboratory Biomarker Analysis
- +2 more
-
Seattle, Washington
- +1 more
Jan 11, 2022
Acute Leukemia in Remission, MDS, Myeloproliferative Syndrome Trial (Fecal Microbiota Transplantation)
Not yet recruiting
- Acute Leukemia in Remission
- +6 more
- Fecal Microbiota Transplantation
-
Amiens, France
- +19 more
Oct 18, 2022